Breast Cancer Clinical Trials
Breast Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for breast Cancer. Corterve aggregates actively recruiting Breast Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Breast Cancer studies
- Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC TrialNCT07474090NAWake Forest University Health SciencesAnatomic Stage I Breast Cancer AJCC v8Winston-Salem, North Carolina
- Phase 1 Study of CLR 125 in Triple Negative Breast CancerNCT07311993PHASE1Cellectar Biosciences, Inc.Breast CancerJacksonville, Florida
- Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)NCT06686394PHASE1, PHASE2Merck Sharp & Dohme LLCBreast NeoplasmsAurora, Colorado
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsNCT06586957PHASE1NiKang Therapeutics, Inc.Solid TumorLittle Rock, Arkansas
- Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)NCT06545682PHASE1M.D. Anderson Cancer CenterMelanoma (Skin Cancer)Houston, Texas
- Phase IIIb Study of Ribociclib + ET in Early Breast CancerNCT05827081PHASE3Novartis PharmaceuticalsEarly Breast CancerBirmingham, Alabama
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialNCT05564377PHASE2National Cancer Institute (NCI)Advanced Malignant Solid NeoplasmBirmingham, Alabama
- A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerNCT07100106PHASE1, PHASE2Genentech, Inc.Breast CancerHuntsville, Alabama
- Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain MetastasesNCT07619534National Cancer Institute (NCI)Breast CancerBethesda, Maryland
- Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast CancerNCT05042687NAM.D. Anderson Cancer CenterBreast CancerHouston, Texas
- Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)NCT06393374PHASE3Merck Sharp & Dohme LLCTriple-Negative Breast CancerMobile, Alabama
- The Breast Cancer Survivors and Partners Online Research Together (SUPORT) ProjectNCT05676255PHASE2University of ArizonaBreast Cancer FemaleTucson, Arizona
Breast Cancer trials by state
Breast Cancer trials by metro
Frequently asked questions
- How do I find recruiting Breast Cancer clinical trials?
- Browse the actively recruiting Breast Cancer studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Breast Cancer clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Breast Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.